C-reactive protein flare predicts response to checkpoint inhibitor treatment in melanoma.
Julian KöttNoah ZimmermannTim ZellIsabel HeidrichGlenn GeidelAlessandra RüngerDaniel J SmitMyriam MerkleNiousha ParnianInga HansenInka HoehneFinn AbeckLeopold TorsterMichael WeichenthalKlaus PantelStefan W SchneiderChristoffer GebhardtPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Early CRP kinetics could indicate a response to ICI with improved OS and RFS/PFS. CRP flare and CRP response indicating significantly improved outcomes compared to CRP non-responders.